Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Website Information
View:
Post by 99942Apophis on Jul 28, 2021 10:16am

Website Information

I talked to Theralase just now and they were unaware that their Website was down was told they will correct. Also asked about the Quarterly Newsletter and was told they were waiting for one more piece of information and it was possible that the Newsletter will be released anytime within a two week timeframe.
Comment by tamarindo1 on Jul 28, 2021 10:30am
Thankyou for the info Apophis.Appreciated.
Comment by tamarindo1 on Jul 28, 2021 10:36am
Is it not a bit odd that from yesterday evening until well past today's opening no one at the company was aware that their website was down.  I guess just not important.
Comment by Gman620 on Jul 28, 2021 10:44am
Thanks for that info, Apophis. Maybe it's close to time to start up some actual discussion here as we get some new information. That would be a refreshing change.
Comment by Impalaman on Jul 28, 2021 10:53am
Their most likely waiting for-1-2 more patients results so they can added to this quarterly---JMO.
Comment by fredgoodwinson on Aug 08, 2021 8:19am
Not saying anything is going on but it was this post 10 days`ago that raised the remote possibility for me. Anything that happened - including the receipt of data - within the Quarter ending on the 30th of June should have been reported out well before now so who knows...???  
Comment by Oilminerdeluxe on Aug 08, 2021 10:35am
Shouldn't there have been more volume if something was up? Yes, sometimes secret stuff remains secret until its released, Or maybe I am just too pessimistic again. Anyway, that newsletter might arrive this week. Hopefully with something good in it and not a copy and paste thing.
Comment by fredgoodwinson on Aug 08, 2021 11:08am
Yep think that there probably should have OMD and maybe even a bit of kidology to fill a time when there`s nothing to say. After past Quarterlys the best i`m expecting is that Rutherrin is now in GLP.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250